Gofen & Glossberg’s Mead Johnson Nutrition Company MJN Stock Holding History

Gofen & Glossberg’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,060	Closed	-$273K	–	481
2017 Q1	$273K	Sell	3,060 -268	-8%	-$22K	0.01%	385
2016 Q4	$235K	Hold	3,328	–	–	0.01%	390
2016 Q3	$263K	Hold	3,328	–	–	0.01%	377
2016 Q2	$302K	Hold	3,328	–	–	0.01%	350
2016 Q1	$283K	Hold	3,328	–	–	0.01%	358
2015 Q4	$263K	Sell	3,328 -475	-12%	-$37.4K	0.01%	367
2015 Q3	$268K	Hold	3,803	–	–	0.01%	363
2015 Q2	$343K	Hold	3,803	–	–	0.01%	331
2015 Q1	$382K	Buy	3,803 +475	+14%	+$47.9K	0.02%	316
2014 Q4	$335K	Hold	3,328	–	–	0.01%	329
2014 Q3	$320K	Hold	3,328	–	–	0.01%	331
2014 Q2	$310K	Hold	3,328	–	–	0.01%	340
2014 Q1	$271K	Hold	3,328	–	–	0.01%	356
2013 Q4	$279K	Hold	3,328	–	–	0.01%	349
2013 Q3	$247K	Hold	3,328	–	–	0.01%	350
2013 Q2	$264K	Buy	+3,328	New	+$267K	0.01%	329

Other funds holding MJN

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

FNBOO

First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Gofen & Glossberg's MJN Position: Q2 2017 in Review

Gofen & Glossberg sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 3,060 shares — an estimated $273K sold.

Gofen & Glossberg first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $382K in Q1 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

Gofen & Glossberg reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
Gofen & Glossberg sold 3,060 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $273K.
Gofen & Glossberg first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
Gofen & Glossberg's Mead Johnson Nutrition Company position peaked at $382K in Q1 2015.
7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Gofen & Glossberg's 13F filing for Q2 2017, filed 16 Aug 2017.